Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The lesion does not extend to the cerebral cortex In the case of cerebral hemorrhage after 0 days after onset, hematoma is absorbed 10m walk is possible by walking alone (balance ability is not included. Contact assistance is also possible) No history of epilepsy or seizures Metals close to the stimulation site (stimulators such as cochlear implants, magnetic clips, deep brain stimulation and vagus nerve stimulation), without a cardiac pacemaker Intracranial titanium products, or magnetically mounted dentures, without implants Intracranial lesions at risk for seizures There is no Those who have not taken medications that lower the seizure threshold (such as tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine). Those who are not complicated by serious physical illness during pregnancy, abuse, withdrawal of alcohol, caffeine or stimulant. Those who do not have cognitive decline or higher brain damage that may affect or be dangerous in the intervention of this study
Exclusion criteria
Exclusion criteria: The lesion does not extend to the cerebral cortex In the case of cerebral hemorrhage after 0 days after onset, hematoma is absorbed 10m walk is possible by walking alone (balance ability is not included. Contact assistance is also possible) No history of epilepsy or seizures Metals close to the stimulation site (stimulators such as cochlear implants, magnetic clips, deep brain stimulation and vagus nerve stimulation), without a cardiac pacemaker Intracranial titanium products, or magnetically mounted dentures, without implants Intracranial lesions at risk for seizures There is no Those who have not taken medications that lower the seizure threshold (such as tricyclic antidepressants, maprotiline, theophylline, methylphenidate, ketamine, clozapine, zotepine). Those who are not complicated by serious physical illness during pregnancy, abuse, withdrawal of alcohol, caffeine or stimulant. Those who do not have cognitive decline or higher brain damage that may affect or be dangerous in the intervention of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brunnstrom recovery stage Fugl-Meyer assessment Modified Ashworth Scale Functional Reach Test Timed Up and Go test 10m gait Functional balance scale BESTEST Functional Ambulation Categories Functional Independence Measure | — |
Countries
Japan
Contacts
Motoyama Rehabilitation Hospital rehabilitation